These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13967132)

  • 21. [Some preliminary clinical observations on the use of a new coronary dilator (RA-8) in syndromes of coronary insufficiency].
    COVA N; BREGANI P
    Minerva Cardioangiol; 1960 Sep; 8():431-6. PubMed ID: 13696065
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical management of coronary artery disease. A resume of its pharmacology.
    CALESNICK B
    Angiology; 1963 Jan; 14():17-22. PubMed ID: 14017870
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phenylpropyldiphenylpropylamine in the treatment of coronary insufficiency syndromes].
    SCALFI U; SANTAGOSTINO A
    Minerva Cardioangiol; 1962 Jun; 10():373-9. PubMed ID: 14497766
    [No Abstract]   [Full Text] [Related]  

  • 24. CHEMOTHERAPY OF CORONARY ARTERY DISEASE: A DOUBLE-BLIND CROSSOVER STUDY OF PETN AND PENTRIUM.
    TALBOT FJ
    Med Ann Dist Columbia; 1965 Jan; 34():19-22. PubMed ID: 14281449
    [No Abstract]   [Full Text] [Related]  

  • 25. [ISOPTIN (D-365), CLINICAL STUDIES ON THE TREATMENT OF CORONARY HEART DISEASE].
    STRAESSLE B; BURCKHARDT D
    Schweiz Med Wochenschr; 1965 May; 95():667-72. PubMed ID: 14305765
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the treatment of coronary heart disease with a selective, long-acting substance, 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-1,2-chromene].
    MAASSEN JH
    Med Klin; 1963 Aug; 58():1269-70. PubMed ID: 13932010
    [No Abstract]   [Full Text] [Related]  

  • 27. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    FRANZINI C; TURRI C; MONTEROSSO A
    Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vasodilator treatment with a derivative of beta-phenylethylamine. Results in 5 cases of arterial syndromes].
    DULAC JF; MANY P; PICARD P
    Presse Med (1893); 1959 Sep; 67():1546-7. PubMed ID: 13818551
    [No Abstract]   [Full Text] [Related]  

  • 29. Specific syndromes of coronary insufficiency and allied cardiopathy.
    RAKOV HL
    N Y State J Med; 1959 May; 59(10):1965-72. PubMed ID: 13644652
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modern therapy of coronary insufficiency].
    Bachmann K
    Z Allgemeinmed; 1970 Aug; 46(24):1200-4. PubMed ID: 5512673
    [No Abstract]   [Full Text] [Related]  

  • 31. [TREATMENT OF CORONARY INSUFFICIENCY WITH INTENSAIN].
    FRIESE G
    Munch Med Wochenschr; 1964 Jun; 106():1084-7. PubMed ID: 14240099
    [No Abstract]   [Full Text] [Related]  

  • 32. [Transcutaneous therapy of chronic coronary insufficiency].
    DI GIUSEPPE F
    Minerva Med; 1960 Apr; 51():1447-52. PubMed ID: 13816412
    [No Abstract]   [Full Text] [Related]  

  • 33. [N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-propylamine, a new synthetic substance for the treatment, from the etiopathogenic viewpoint, of myocardiopathies caused by coronary insufficiency].
    PICCINELLI O
    Farmaco Prat; 1961 Dec; 16():617-25. PubMed ID: 14038347
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of coronary insufficiency with a new diphenylpropylamine derivative].
    ARCURI F; PORTA A
    Minerva Cardioangiol; 1962 Sep; 10():624-9. PubMed ID: 14013632
    [No Abstract]   [Full Text] [Related]  

  • 35. [Persantin, a new substance for therapy of coronary insufficiency].
    JUNEMANN P
    Munch Med Wochenschr; 1959 Feb; 101(8):340-1. PubMed ID: 13644100
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical trials with persantin in the therapy of coronary and myocardial insufficiency].
    ROESELER E
    Med Welt; 1960 Nov; 48():2562-4. PubMed ID: 13742702
    [No Abstract]   [Full Text] [Related]  

  • 37. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease.
    Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A
    Int J Cardiol; 2005 Oct; 105(1):58-66. PubMed ID: 16207546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imolamine in acute coronary insufficiency. Some considerations in the light of 30 treated cases].
    Caporicci D
    Clin Ter; 1977 Mar; 80(6):553-85. PubMed ID: 862356
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of cloridarol in coronary insufficiency].
    Mossuti E; Nigro P; Diene G; Petralito A
    Minerva Med; 1976 Apr; 67(21):1394-7. PubMed ID: 934497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(20):867-73. PubMed ID: 3936287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.